General MedicationsINTRAVENOUSStandard
NEPHROSCAN
TECHNETIUM TC-99M SUCCIMER
Standard Dose
N/A
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary
Approval overview NEPHROSCAN is listed in Drugs@FDA under application 214993 (NDA).
Review priority: PRIORITY Marketing status: Prescription Active ingredient TECHNETIUM TC-99M SUCCIMER Form and strength POWDER;INTRAVENOUS - N/A Sponsor THERAGNOSTICS Submission history Latest submission status date: 2022-02-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview NEPHROSCAN is listed in Drugs@FDA under application 214993 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient TECHNETIUM TC-99M SUCCIMER Form and strength POWDER;INTRAVENOUS - N/A Sponsor THERAGNOSTICS Submission history Latest submission status date: 2022-02-18 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.